ASCO 2026 wasn’t just about new data—it highlighted where oncology is headed next. From breakthrough in vivo CAR-T results and RAS-targeted therapies to the growing influence of Chinese biotech on the global stage, this year’s meeting showcased the evolving future of cancer care. Listen to the recap: https://www.fiercepharma.com/pharma/behind-headlines-asco-2026
More Tips From The Bandish Group
How the Way You Speak Can Influence Career Advancement
◆
The way we communicate at work can influence career opportunities in ways that go beyond experience, qualifications, and job performance.…
Why Choose a Boutique Executive Search Firm?
◆
Boutique comes from a French word meaning any small shop and it often has an air of exclusivity. Founded in…